L1 Capital trimmed its position in the company due to share price appreciation, noting the stock has more than tripled since early 2020. A separate analysis suggests the company's intrinsic value is potentially 88% above its current share price, with a fair value estimate of $900 based on free cash flow. The company also announced the promotion of Erica Rossitto to Senior Vice President and Chief Nurse Executive, effective February 2026.